ロード中...
Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker
Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the s...
保存先:
| 出版年: | Iran J Pharm Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Shaheed Beheshti University of Medical Sciences
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6934949/ https://ncbi.nlm.nih.gov/pubmed/32641945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.1100768 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|